CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 34 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,177,080 | -33.0% | 4,463,000 | -12.6% | 0.00% | 0.0% |
| Q2 2023 | $7,722,825 | +26.8% | 5,106,000 | +2.2% | 0.00% | 0.0% |
| Q1 2023 | $6,089,000 | +105064.1% | 4,997,000 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $5,790 | -99.9% | 5,007,000 | +13.8% | 0.00% | 0.0% |
| Q3 2022 | $4,847,000 | +15.8% | 4,401,000 | +27.2% | 0.00% | 0.0% |
| Q2 2022 | $4,184,000 | +165.3% | 3,461,000 | +276.2% | 0.00% | – |
| Q1 2022 | $1,577,000 | +287.5% | 920,000 | +280.2% | 0.00% | – |
| Q4 2021 | $407,000 | +4422.2% | 242,000 | +3933.3% | 0.00% | – |
| Q3 2021 | $9,000 | -99.7% | 6,000 | -99.7% | 0.00% | – |
| Q2 2021 | $3,424,000 | +20.1% | 2,118,000 | +18.1% | 0.00% | – |
| Q1 2021 | $2,852,000 | +75.2% | 1,794,000 | +52.4% | 0.00% | – |
| Q4 2020 | $1,628,000 | +48.8% | 1,177,000 | +20.3% | 0.00% | – |
| Q3 2020 | $1,094,000 | -64.2% | 978,000 | -66.7% | 0.00% | -100.0% |
| Q2 2020 | $3,060,000 | – | 2,933,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |